Ampyra (dalfampridine) SR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ampyra (dalfampridine) SR, covering 2014-07-04 to 2014-07-04. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials. [Phase 3]